Rich Mazzola

Rich Mazzola is an experienced finance professional with a strong background in medical technology and consulting. Currently serving as CFO and Co-Founder at Project Medtech since November 2020, Mazzola focuses on the development and delivery of innovative medical technologies. As CFO of Resivant Medical, LLC since July 2023, Mazzola is involved in the development of Cutiva(TM), a next-generation topical skin closure system. Additionally, Mazzola is a Board Member at STMPatch, which aims to enhance health and wellness through equitable vaccine access. Previous roles include independent consultancy and directorial positions at Pease Bell, CPAs, managerial positions at Marcum LLP and Skoda Minotti, and a directorial role at Drips. Mazzola holds a Bachelor of Science degree in Business Administration with a concentration in Accountancy from John Carroll University.